식품의약품안전처가 희귀암을 유발할 가능성이 제기된 엘러간의 인공유방 보형물 '내트렐 텍스쳐드' 등 일부 제품 회수에 착수했다.
The Ministry of Food and Drug Safety has begun to collect some products, including Allergan's artificial breast implants "Natrelle Textured", which are likely to cause rare cancer.